Can you contract infectious mononucleosis (mono) more than once and what tests are used to diagnose a second infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Have Mono More Than Once?

True recurrent infectious mononucleosis from Epstein-Barr virus (EBV) is extremely rare because after primary infection, the virus establishes lifelong latency and individuals develop lasting immunity, making a second episode of clinical mononucleosis highly unlikely in immunocompetent patients. 1

Understanding EBV Infection and Immunity

After primary EBV infection, the virus persists in B-cells with minimal latent gene expression, controlled by EBV-specific cytotoxic T-lymphocytes. 1 Over 90% of adults worldwide are seropositive for EBV, indicating past infection and immunity. 1, 2 Once infected, antibodies to EBNA (Epstein-Barr nuclear antigen) develop 1-2 months after primary infection and remain detectable for life, providing lasting immunity. 1

What appears to be "recurrent mono" is typically one of the following:

  • Initial misdiagnosis - The first illness may have been caused by cytomegalovirus (CMV), adenovirus, HIV, or Toxoplasma gondii, which can all cause mononucleosis-like syndromes 1
  • Reactivation in immunocompromised patients - Not true recurrence but viral reactivation when T-cell immunosurveillance is impaired 1
  • Different infection entirely - The second illness may be an unrelated condition mimicking mononucleosis 3

Testing for Suspected Second Infection

When a patient presents with mononucleosis-like symptoms and reports having had mono previously, the diagnostic approach should differentiate between true EBV reinfection (extremely rare), reactivation, or an alternative diagnosis:

Initial Testing Algorithm

  1. Complete blood count with differential 4

    • Look for >40% lymphocytes and >10% atypical lymphocytes
    • Atypical lymphocytosis ≥20% or ≥10% atypical lymphocytes plus ≥50% total lymphocytosis strongly supports acute infection 3
  2. Heterophile antibody test (Monospot) 1, 4

    • Sensitivity 87%, specificity 91% 4
    • Important caveat: False-negative results occur in approximately 10% of patients, especially in children <10 years and during the first week of illness 1, 4
    • Heterophile antibodies become detectable between days 6-10 after symptom onset 1

When Heterophile Test is Negative

If clinical suspicion remains high despite negative heterophile testing, proceed with EBV-specific antibody testing: 1

  1. EBV Viral Capsid Antigen (VCA) and EBNA antibody panel 1

Interpretation patterns:

  • Recent primary infection: VCA IgM positive (with or without VCA IgG), EBNA negative 1, 5
  • Past infection (>6 weeks): VCA IgG positive, EBNA positive, VCA IgM negative 1
  • Not EBV: All negative - consider alternative diagnoses like CMV, HIV, toxoplasmosis 1

If the patient has positive EBNA antibodies, this indicates infection occurred more than 6 weeks prior and EBV is NOT the cause of current symptoms. 1 In this scenario, you must investigate alternative causes of the mononucleosis-like syndrome.

Critical Clinical Caveats

  • Approximately 5-10% of EBV-infected patients fail to develop EBNA antibodies, which can complicate interpretation 1
  • Immunocompromised patients (transplant recipients, HIV patients, those on immunosuppressive therapy) can develop EBV-associated lymphoproliferative disease rather than typical mononucleosis, requiring EBV viral load testing via nucleic acid amplification testing (NAAT) 1
  • In immunosuppressed IBD patients on thiopurines, primary EBV infection carries particular risk, with fatal cases reported 1
  • Elevated liver enzymes increase clinical suspicion for infectious mononucleosis when heterophile testing is negative 4

Alternative Diagnoses to Consider

When evaluating suspected "recurrent mono," systematically exclude:

  • Cytomegalovirus infection 1
  • Acute HIV infection 1
  • Toxoplasmosis 1, 3
  • Streptococcal pharyngitis 3
  • Adenovirus infection 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Infectious mononucleosis--a "childhood disease" of great medical concern].

Medizinische Monatsschrift fur Pharmazeuten, 2013

Research

Epstein-Barr virus infectious mononucleosis.

American family physician, 2004

Research

Infectious Mononucleosis: Rapid Evidence Review.

American family physician, 2023

Guideline

Epstein-Barr Virus Infection Diagnosis and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.